Association between intestinal flora and secondary resistance to imatinib in gastrointestinal stromal tumors
Medical Journal of Chinese People′s Liberation ArmyVol. 50, Issue 3, Pages: 277-283(2025)
Special Issue on Role of Gut Microbiota in Disease Occurrence and Treatment|更新时间:2025-04-18
分享给微信好友或者朋友圈
导出参考文献
Association between intestinal flora and secondary resistance to imatinib in gastrointestinal stromal tumors
“In the field of gastrointestinal stromal tumor treatment, experts have explored the correlation between gut microbiota and tumor drug resistance, providing new ideas for clinical treatment.”
作者机构:
1.空军军医大学第一附属医院/西京消化病医院消化外科,陕西西安 710032
2.空军军医大学西京消化病医院消化系肿瘤整合防治全国重点实验室,陕西西安 710032
3.空军军医大学基础医学院学员五大队,陕西西安 710032
作者简介:
Email: yangjj@fmmu.edu.cn
基金信息:
the Key Research and Development Project of Shaanxi Province(2022ZDLSF03-04);the Innovative Exploratory Project of the State Key Laboratory of Tumor Biology(CBSKL2022ZZ41)
Li Hao-Lin,Wang Shu,Zhao Yan,et al.Association between intestinal flora and secondary resistance to imatinib in gastrointestinal stromal tumors[J].Medical Journal of Chinese People′s Liberation Army,2025,50(03):277-283.
Li Hao-Lin,Wang Shu,Zhao Yan,et al.Association between intestinal flora and secondary resistance to imatinib in gastrointestinal stromal tumors[J].Medical Journal of Chinese People′s Liberation Army,2025,50(03):277-283. DOI: 10.11855/j.issn.0577-7402.0056.2024.0620.
Association between intestinal flora and secondary resistance to imatinib in gastrointestinal stromal tumors
Analysis of drug resistance in disseminated pulmonary tuberculosis: 71 cases report
Clinical characteristics and drug resistance of lower respiratory tract infection with Streptococcus pneumoniae
Effect of Huaier on reversing the drug resistance of CEM-C1 cells in human acute T lymphoblastic leukemia and its mechanism
Related Author
Yang Jian-Jun
Zhao Yan
Wang Shu
Li Hao-lin
Yan Jun
Shi Yi-Heng
Wang Chao-Hong
Yang Bin
Related Institution
The Fifth Cadet Brigade of School of Basic Medicine, Air Force Military Medical University
State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Xijing Hospital of Digestive Diseases, Air Force Military Medical University
Department of Digestive Surgery, Xijing Hospital of Digestive Diseases/the First Affiliated Hospital of Air Force Military Medical University
Department of Clinical Laboratory, Beijing Chest Hospital of Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Institute
Department of Clinical Laboratory, Beijing Chest Hospital of Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Institue